Kevin T. Conroy - Feb 14, 2022 Form 4 Insider Report for EXACT SCIENCES CORP (EXAS)

Role
President and CEO, Director
Signature
/s/ Kevin T. Conroy by Mark R. Busch, attorney-in-fact
Stock symbol
EXAS
Transactions as of
Feb 14, 2022
Transactions value $
$3,195,768
Form type
4
Date filed
2/16/2022, 07:08 PM
Previous filing
Jan 28, 2022
Next filing
Feb 24, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EXAS Common Stock Options Exercise $856K +94.4K +14.08% $9.07* 765K Feb 14, 2022 Direct F1
transaction EXAS Common Stock Options Exercise $1.05M +96.8K +12.64% $10.82* 862K Feb 14, 2022 Direct F1
transaction EXAS Common Stock Options Exercise $2.44M +31.1K +3.61% $78.33 893K Feb 14, 2022 Direct F2
transaction EXAS Common Stock Sale -$1.15M -14.4K -1.61% $79.55 879K Feb 15, 2022 Direct F3, F4
holding EXAS Common Stock 26.6K Feb 14, 2022 Held in 401(k) Plan
holding EXAS Common Stock 21.7K Feb 14, 2022 Held in Grantor Retained Annuity Trust
holding EXAS Common Stock 21.7K Feb 14, 2022 Held in Grantor Retained Annuity Trust
holding EXAS Common Stock 21.7K Feb 14, 2022 Held in Grantor Retained Annuity Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EXAS Stock Option (right to buy) Options Exercise $0 -94.4K -100% $0.00* 0 Feb 14, 2022 Common Stock 94.4K $9.07 Direct F5
transaction EXAS Stock Option (right to buy) Options Exercise $0 -96.8K -100% $0.00* 0 Feb 14, 2022 Common Stock 96.8K $10.82 Direct F6
transaction EXAS Restricted Stock Units Options Exercise $0 -31.1K -33.33% $0.00 62.3K Feb 14, 2022 Common Stock 31.1K Direct F7, F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of Common Stock acquired upon the exercise of options in an exercise-and-hold transaction.
F2 Represents shares of common stock received upon vesting of a restricted stock unit award.
F3 Represents shares sold pursuant to a Sell-to-Cover Rule 10b5-1 Plan to pay withholding taxes due in connection with the vesting of certain restricted stock units on February 14, 2022.
F4 In addition to the shares of Common Stock reported on this Form 4, which total 970,448 shares, Mr. Conroy also holds, in the aggregate, an additional 985,601 vested and unvested options to purchase shares of Common Stock and restricted stock units, with each restricted stock unit representing a contingent right to receive one share of Common Stock.
F5 These options vested in full on February 27, 2016.
F6 These options vested in full on February 22, 2017.
F7 Each restricted stock unit represents a contingent right to receive one share of common stock.
F8 Represents a restricted stock unit award that partially vested on February 14, 2022. The restricted stock units vest in four equal annual installments beginning on February 14, 2021.